LifespanningRx review

LifespanningRx names its Miami corporation, states pharmacy quality standards and displays one-time supply prices. Its product pages show sermorelin at $186 for one month or $506 for three, NAD⁺ at $197 or $482, and glutathione at $146 or $246. A banner still advertises a quarterly buy-two-get-one subscription, but those three-month totals are not twice the one-month amounts and no active renewal debit is clear. Confirm the actual offer before paying.

LifespanningRx is a clinician-guided longevity and peptide telehealth brand operated by Lifespanning Media Corp., a Florida corporation at 495 Brickell Ave, Miami. Its storefront sells sermorelin, a high-dose NAD⁺ injection and glutathione at published prices within what it describes as more than fifty peptide therapies, alongside a compounded GLP-1 weight-loss program using semaglutide and tirzepatide. It also runs a turnkey white-label platform that lets clinics, trainers and wellness brands offer the same prescription therapies to their own audiences, so the consumer brand is only half the business.

LifespanningRx describes online screening, a virtual consultation and clinician approval before a prescription is sent to a licensed US compounding pharmacy. It says the evaluation is included and there is no membership fee. Its quality claims include sourcing checks, potency and sterility testing, AQL inspection and a certificate of conformance, though individual certificates and dispensing pharmacies are not named. The consumer site claims service in 48-plus states and Washington DC; its partner page says 48 states excluding Alabama and Mississippi. Availability can vary by therapy and state. Partner clinics may use the same platform under their own brands and prices. No public patient lab fee or dose-dependent final quote was established.

The visible purchase selectors list one-time supply choices: sermorelin $186 for one month or $506 for three, NAD⁺ injection $197 or $482, and glutathione injection $146 or $246. A separate sermorelin landing page says from $169 per month with a multi-month plan, approximately the $506 three-month total divided by three. A banner still offers a buy-two-get-one quarterly subscription, but the displayed three-month totals do not equal twice the one-month prices. The site's catalog also carries recurring-delivery plans at those same supply prices, though the visible selectors showed only one-time purchases; confirm whether a subscription can actually be selected, its debit and renewal cadence. Evaluation is described as included and membership as free; the refund policy separately refers to a consultation fee, so confirm any fee in the final quote. The refund policy requires at least seven days’ notice for renewals. Medication becomes nonrefundable once the prescription is transmitted or compounding begins, and a consultation fee is nonrefundable after review starts.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. LifespanningRx states that prescriptions are fulfilled by US-registered pharmacies and that it works with 503A and 503B licensed pharmacy partners, and it says it is LegitScript-certified — but individual pharmacies are not named, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are, which is exactly why its published potency and sterility testing chain is worth something even unverified. On the evidence, the three molecules it leads with are not equivalent. Sermorelin is a GHRH analog acting on your own pituitary — a real, well-characterized mechanism whose long-term human outcome data remains thin. Injected NAD⁺ has no controlled human outcome trials; the NAD⁺ forms with human data are the oral precursors NR and NMN, and what they show is a raised blood NAD⁺ level, a biomarker rather than a clinical outcome. Injectable glutathione has essentially no controlled human outcome data behind the detoxification and antioxidant claims made for it. A "50+ peptide therapies" menu will necessarily contain molecules with far less evidence than these three, so ask what the specific molecule is before agreeing to a protocol. Individual results vary.